Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Cannabidiol as a novel candidate alcohol use disorder pharmacotherapy: a systematic review.

Turna J, Syan SK, Frey BN, Rush B, Costello J, Weiss M, MacKillop J.

Alcohol Clin Exp Res. 2019 Jan 30. doi: 10.1111/acer.13964. [Epub ahead of print]

PMID:
30698831
2.

Survey of Australian psychiatrists' and psychiatry trainees' knowledge about and attitudes towards medicinal cannabinoids.

Jacobs NI, Montebello M, Monds LA, Lintzeris N.

Australas Psychiatry. 2019 Feb;27(1):80-85. doi: 10.1177/1039856218803675. Epub 2018 Oct 9.

PMID:
30298754
3.

Unique treatment potential of cannabidiol for the prevention of relapse to drug use.

Weiss F, Gonzalez-Cuevas G.

Neuropsychopharmacology. 2019 Jan;44(1):229. doi: 10.1038/s41386-018-0218-2. No abstract available.

PMID:
30254292
4.

Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework.

Greenwald MK.

Neurobiol Stress. 2018 Aug 11;9:84-104. doi: 10.1016/j.ynstr.2018.08.003. eCollection 2018 Nov. Review.

5.

Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV).

Mersiades AJ, Tognela A, Haber PS, Stockler M, Lintzeris N, Simes J, McGregor I, Olver I, Allsop DJ, Gedye C, Kirby AC, Morton RL, Fox P, Clarke S, Briscoe K, Aghmesheh M, Wong N, Walsh A, Hahn C, Grimison P.

BMJ Open. 2018 Sep 12;8(9):e020745. doi: 10.1136/bmjopen-2017-020745.

6.

Important Questions About the Impact of Medical Marijuana on People With Serious Mental Illness.

Brunette MF, Borodovsky JT, Myers M, Budney AJ.

Psychiatr Serv. 2018 Sep 6:appips201800210. doi: 10.1176/appi.ps.201800210. [Epub ahead of print]

PMID:
30185124
7.

Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community.

Suraev A, Lintzeris N, Stuart J, Kevin RC, Blackburn R, Richards E, Arnold JC, Ireland C, Todd L, Allsop DJ, McGregor IS.

Sci Rep. 2018 Jul 5;8(1):10154. doi: 10.1038/s41598-018-28127-0. Erratum in: Sci Rep. 2018 Aug 2;8(1):11850.

8.

Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats.

Javadi-Paydar M, Nguyen JD, Kerr TM, Grant Y, Vandewater SA, Cole M, Taffe MA.

Psychopharmacology (Berl). 2018 Sep;235(9):2541-2557. doi: 10.1007/s00213-018-4946-0. Epub 2018 Jun 16.

PMID:
29907926
9.

Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.

Bhardwaj AK, Allsop DJ, Copeland J, McGregor IS, Dunlop A, Shanahan M, Bruno R, Phung N, Montebello M, Sadler C, Gugusheff J, Jackson M, Luksza J, Lintzeris N; Agonist Replacement for Cannabis Dependence (ARCD) study group.

BMC Psychiatry. 2018 May 18;18(1):140. doi: 10.1186/s12888-018-1682-2.

10.

Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle.

Gonzalez-Cuevas G, Martin-Fardon R, Kerr TM, Stouffer DG, Parsons LH, Hammell DC, Banks SL, Stinchcomb AL, Weiss F.

Neuropsychopharmacology. 2018 Sep;43(10):2036-2045. doi: 10.1038/s41386-018-0050-8. Epub 2018 Mar 22.

11.

Police probe of Brazilian marijuana researcher sparks protests.

Angelo C.

Nature. 2018 Mar 15;555(7696):296. doi: 10.1038/d41586-018-02842-0. No abstract available.

PMID:
29542710
12.

Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence.

Stockings E, Zagic D, Campbell G, Weier M, Hall WD, Nielsen S, Herkes GK, Farrell M, Degenhardt L.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):741-753. doi: 10.1136/jnnp-2017-317168. Epub 2018 Mar 6. Review.

PMID:
29511052
13.

Police documentation of drug use in injured drivers: Implications for monitoring and preventing drug-impaired driving.

Brubacher JR, Chan H, Erdelyi S, Asbridge M, Mann RE, Purssell RA, Solomon R.

Accid Anal Prev. 2018 Sep;118:200-206. doi: 10.1016/j.aap.2018.02.018. Epub 2018 Feb 23.

PMID:
29482896
14.

Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury.

Wang Y, Mukhopadhyay P, Cao Z, Wang H, Feng D, Haskó G, Mechoulam R, Gao B, Pacher P.

Sci Rep. 2017 Sep 21;7(1):12064. doi: 10.1038/s41598-017-10924-8.

15.

Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations.

Fischer B, Russell C, Sabioni P, van den Brink W, Le Foll B, Hall W, Rehm J, Room R.

Am J Public Health. 2017 Aug;107(8):e1-e12. doi: 10.2105/AJPH.2017.303818. Epub 2017 Jun 23. Review.

PMID:
28644037
16.

The endocannabinoid system as a target for addiction treatment: Trials and tribulations.

Sloan ME, Gowin JL, Ramchandani VA, Hurd YL, Le Foll B.

Neuropharmacology. 2017 Sep 15;124:73-83. doi: 10.1016/j.neuropharm.2017.05.031. Epub 2017 May 28. Review.

PMID:
28564576
17.

The Standard Joint Unit.

Casajuana Kögel C, Balcells-Olivero MM, López-Pelayo H, Miquel L, Teixidó L, Colom J, Nutt DJ, Rehm J, Gual A.

Drug Alcohol Depend. 2017 Jul 1;176:109-116. doi: 10.1016/j.drugalcdep.2017.03.010. Epub 2017 May 16.

PMID:
28531767
18.

The endocannabinoid system as a target for novel anxiolytic drugs.

Patel S, Hill MN, Cheer JF, Wotjak CT, Holmes A.

Neurosci Biobehav Rev. 2017 May;76(Pt A):56-66. doi: 10.1016/j.neubiorev.2016.12.033. Review.

19.

Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines.

Arellano AL, Papaseit E, Romaguera A, Torrens M, Farré M.

CNS Neurol Disord Drug Targets. 2017;16(5):554-566. doi: 10.2174/1871527316666170413104516. Review.

PMID:
28412920
20.

Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses.

Lawn W, Freeman TP, Pope RA, Joye A, Harvey L, Hindocha C, Mokrysz C, Moss A, Wall MB, Bloomfield MA, Das RK, Morgan CJ, Nutt DJ, Curran HV.

Psychopharmacology (Berl). 2016 Oct;233(19-20):3537-52. doi: 10.1007/s00213-016-4383-x. Epub 2016 Sep 2.

Supplemental Content

Loading ...
Support Center